Skip to content

Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory Duct

Long Term Evolution of the Anterograde Refractory Period of Accessory Duct in the Wolff-Parkinson-White Syndrome

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00873470
Acronym
WPW
Enrollment
13
Registered
2009-04-01
Start date
2009-02-28
Completion date
2012-12-31
Last updated
2013-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wolff-Parkinson-White Syndrome

Brief summary

The study consists of the realization of a new esophageal stimulation for patients already stimulated 10 years ago. The investigators would like to make a long term evaluation of the evolution of anterograde effective refractory period of accessory duct in the WPW syndrome. This study will be realized by esophageal stimulation.

Interventions

PROCEDUREesophagal stimulation

ECG (rest) esophagal stimulation (rest and during effort)

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* 21 \< age \< 64 years * First esophagal stimulation with evaluation of effective anterograde refractory period \> 10 years * Informed consent signed * Diagnosis of Wolff-Parkinson-White syndrome * No procedure of ablation of accessory duct

Exclusion criteria

* Ablation of accessory duct * Patient with contraindication to esophageal stimulation * Patient with contraindication to effort test

Design outcomes

Primary

MeasureTime frame
Measurement of effective anterograde refractory period of accessory duct and its evolution for a follow up superior to 10 yearsDay 0

Secondary

MeasureTime frame
Triggering a supra-ventricular tachycardia during the stimulation.Day 0
Presence of symptoms linked to WPW syndrome during the interval separating the 2 esophageal stimulation.Day 0

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026